Avenue Therapeutics Information

View Top Employees from Avenue Therapeutics

Avenue Therapeutics, Inc. (OTC: ATXI), a Fortress Biotech (NASDAQ: FBIO) subsidiary, is a specialty pharmaceutical company focused on the development and commercialization of therapies for rare and neurologic diseases. Please be aware of Recruiting Fraud: https://www.avenuetx.com/beware-of-recruiting-fraud/

Website	http://www.avenuetx.com
Ticker	ATXI
Revenue	$1 million
Employees	10 (6 on RocketReach)
Founded	2015
Address	1111 Kane Concourse, 301, Bay Harbor Islands, Florida 33154, US
Technologies	JavaScript , HTML , PHP +27 more (view full list)
Industry	Biotechnology Research, Business Services General, Pharmaceutical, Business Services, Health Care
Keywords	Specialty Pharmaceuticals, Pharmaceutical Company, Drug Development, Biotechnology, Clinical Trials, Fda Approval, Drug Manufacturing, Pharmaceutical Research, Prescription Drugs, Generic Drugs, Healthcare, Medicine, Biopharma, Health, Treatment, Therapy, Patient Care, Pharmacy, Medical, Drugs
Competitors	Sage Therapeutics, Ultragenyx Brasil, Neurocrine Biosciences, Lilly India, AstraZeneca, Pfizer, Bristol Myers Squibb, Otsuka Pharmaceutical Companies (U.S.), Novartis, Johnson & Johnson +40 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 873 Companies, SIC Code 87 Companies, SIC Code 283 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies